Cmin for MR-formulations? [Regulatives / Guidelines]

posted by Marcel – 2010-04-23 12:09 (5535 d 21:54 ago) – Posting: # 5196
Views: 23,192

❝ The MR guidance is a little bit outdated (1999) - and you may expect that regulators are quite aware about recent developments. The current workprogramme of EMA's EWP states that a revision of CPMP/EWP/280/96 is to be considered in 2010.


Is this still the case? I'm looking through the current work programme for 2010 and can't find anything on this in it. If this is still the case, in your opinion can we expect a draft guidance out in 2010?

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
37 visitors (0 registered, 37 guests [including 11 identified bots]).
Forum time: 10:03 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5